These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31839729)

  • 41. Routine preoperative blood testing in pediatric neurosurgery.
    Almesbah F; Mandiwanza T; Kaliaperumal C; Caird J; Crimmins D
    J Neurosurg Pediatr; 2013 Dec; 12(6):615-21. PubMed ID: 24093590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of the activated partial thromboplastin time for the diagnosis of congenital coagulation disorders: problems and possible solutions.
    Barna L; Triplett DA
    Ric Clin Lab; 1989; 19(4):345-54. PubMed ID: 2517350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults.
    Kamal AH; Tefferi A; Pruthi RK
    Mayo Clin Proc; 2007 Jul; 82(7):864-73. PubMed ID: 17605969
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Could light meal jeopardize laboratory coagulation tests?
    Lima-Oliveira G; Salvagno GL; Lippi G; Danese E; Gelati M; Montagnana M; Picheth G; Guidi GC
    Biochem Med (Zagreb); 2014; 24(3):343-9. PubMed ID: 25351352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reference intervals for common coagulation tests of preterm infants (CME).
    Christensen RD; Baer VL; Lambert DK; Henry E; Ilstrup SJ; Bennett ST
    Transfusion; 2014 Mar; 54(3):627-32:quiz 626. PubMed ID: 23834237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reference values for rotational thromboelastometry (ROTEM) in clinically healthy cats.
    Marly-Voquer C; Riond B; Jud Schefer R; Kutter AP
    J Vet Emerg Crit Care (San Antonio); 2017 Mar; 27(2):185-192. PubMed ID: 28166379
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pneumatic tube system transport does not alter platelet function in optical and whole blood aggregometry, prothrombin time, activated partial thromboplastin time, platelet count and fibrinogen in patients on anti-platelet drug therapy.
    Enko D; Mangge H; Münch A; Niedrist T; Mahla E; Metzler H; Prüller F
    Biochem Med (Zagreb); 2017 Feb; 27(1):217-224. PubMed ID: 28392742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and laboratory diagnosis of rare coagulation disorders (RCDs).
    Menegatti M; Palla R
    Thromb Res; 2020 Dec; 196():603-608. PubMed ID: 31515069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical impact of increased sensitivity PT and APTT coagulation assays.
    Wojtkowski TA; Rutledge JC; Matthews DC
    Am J Clin Pathol; 1999 Aug; 112(2):225-32. PubMed ID: 10439803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing.
    Tripodi A; Chantarangkul V; Mannucci PM
    Br J Haematol; 2009 Oct; 147(1):77-82. PubMed ID: 19659548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of tris-hydroxymethylaminomethane on reversing coagulation abnormalities caused by acidosis in pigs.
    Martini WZ; Dubick MA; Wade CE; Holcomb JB
    Crit Care Med; 2007 Jun; 35(6):1568-74. PubMed ID: 17452929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of using a roller mixer on rejected samples in coagulation tests.
    Aral H; Usta M
    Int J Lab Hematol; 2011 Dec; 33(6):617-9. PubMed ID: 21569221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clot activators and anticoagulant additives for blood collection. A critical review on behalf of COLABIOCLI WG-PRE-LATAM.
    Lima-Oliveira G; Brennan-Bourdon LM; Varela B; Arredondo ME; Aranda E; Flores S; Ochoa P
    Crit Rev Clin Lab Sci; 2021 May; 58(3):207-224. PubMed ID: 33929278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal coagulation profiles in tonsillectomy and adenoidectomy patients.
    Schmidt JL; Yaremchuk KL; Mickelson SA
    Henry Ford Hosp Med J; 1990; 38(1):33-5. PubMed ID: 2228707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mixing test for prolonged clotting time: clinical availability and problems].
    Uchiba M; Ando Y
    Rinsho Byori; 2009 Oct; 57(10):1004-12. PubMed ID: 19928499
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding.
    Murray D; Pennell B; Olson J
    Transfusion; 1999 Jan; 39(1):56-62. PubMed ID: 9920167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laboratory management of the bleeding patient.
    Taylor LJ
    Clin Lab Sci; 2003; 16(2):111-4. PubMed ID: 12757191
    [No Abstract]   [Full Text] [Related]  

  • 58. Contamination of coagulation tests with heparin from blood gas samples.
    Brown JM; Dimeski G
    Br J Anaesth; 2001 Oct; 87(4):628-9. PubMed ID: 11878734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of fibrinogen degradation products on thrombin time, activated partial thromboplastin time and prothrombin time of canine plasma.
    Mischke R; Wolling H
    Haemostasis; 2000; 30(3):123-30. PubMed ID: 11014962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Unsuspected prolonged activated partial thromboplastin time in emergency surgery. Diagnostic and therapeutic guide].
    Barrio J; Peris V; Asensio I; Molina I; López F; García V
    Rev Esp Anestesiol Reanim; 2002 Oct; 49(8):424-7. PubMed ID: 12455323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.